Coverage
-
May 24, 2021
The Patent Trial and Appeal Board has thrown out more than two dozen claims in a University of Minnesota patent covering a compound with antiviral and anti-cancer properties, handing a win to Gilead in a sprawling patent fight.
2 other articles on this case.
View all »